Eli Lilly acquisition of blood-cancer developer leads a day of cross-border corporate shakeups Eli Lilly acquisition bolsters the drugmaker’s hematology pipeline while China blocks a major Meta AI deal and …
The Berlin Herald @2020 – All Right Reserved.